Daily Briefing for November 12, 2026

AMA says AI cannot be licensed as a doctor and vendors should own its errors

The voices on this episode are generated, and so is the script, from the day's post at Physician in the Loop. Every fact in the post links to its source.

Read the post and its sources

Get the free email briefing

The American Medical Association's House of Delegates voted Nov. 9 that artificial intelligence cannot hold a medical license or a physician's title, and that vendors should be liable when a defective tool harms a patient.

The policy, released Nov. 10, says AI belongs in physician-led teams and seeks liability protection for physicians who decline an AI recommendation. A West Health-Gallup survey found 56% of patients comfortable with AI diagnosis that a clinician can override, against the 36% that primary care physicians predicted.

Oura agreed to buy AI primary care company Counsel Health for $625 million in cash. The FDA classified a correction of 80,938 Tandem Mobi insulin pumps as its most serious recall type, and two trials published this week address clot prevention after joint replacement and blood pressure drugs on the morning of surgery.

In this episode

• AMA delegates vote that AI cannot hold a medical license or a physician's title, and that vendors should be liable for defective tools
• Patients are more comfortable with AI diagnosis than their doctors think, with a 20-point gap when a clinician can override it
• Oura agrees to buy Counsel Health, whose AI chats escalate to physicians who can diagnose and prescribe, for $625 million in cash
• False alarms on 80,938 Tandem Mobi insulin pumps can halt insulin delivery, in a top-tier recall tied to 230 adverse events
• Aspirin fails to prove noninferior to rivaroxaban or warfarin for clot prevention after hip or knee replacement in an 18,883-patient trial
• Holding ACE inhibitors or ARBs the morning of surgery cuts perioperative hypotension to 31% from 46% in older patients